Piper Sandler Upgrades Tvardi Therapeutics Inc (TVRD) to Overweight
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi upgraded Tvardi Therapeutics Inc (NASDAQ: TVRD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
